13F

Stock

Allogene Therapeutics, Inc.

ALLO · held by 9 managers

Reported value

$3.68M

Holders

9

+1 new · −0 exited

Holders’ est. mark

$65.9K

Price effect on 3 books still in the name

Largest holder

$1.61M

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY1.3M$1.61MHeld
BANK OF AMERICA CORP /DE/974.3K$1.21MHeld
BARCLAYS PLC599K$742.8K$65.9KAdded$13.5K
TUDOR INVESTMENT CORP ET AL71K$88KHeld
Allworth Financial LP13.1K$16.2KHeld
Essential Partners LLC7.68K$9.52KNew
IFP Advisors, Inc1.04K$1.29KHeld
Leonteq Securities AG351$435$38Added$38
NWI MANAGEMENT LP100K$124$11Added$11

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.